Overview

A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

This aim of this study is to determine the safety and tolerability of elesclomol sodium at escalating doses (ultimately identifying the maximum tolerated dose) when combined with a fixed dose of docetaxel and concomitant prednisone. This study will also characterize the pharmacokinetics of elesclomol and docetaxel.

Phase:

Phase 1

Details

Lead Sponsor:

Synta Pharmaceuticals Corp.

Treatments:

Docetaxel
Prednisone